UBS Upgrades Thermo Fisher Scientific (NYSE: TMO) Amidst Strategic Growth and Market Dynamics

• UBS has upgraded Thermo Fisher Scientific Inc. (NYSE: TMO) to a "Buy" rating with a price target of $730.00, indicating a potential upside of 21.06%.
• Strategic acquisitions and the launch of the new Thermo Scientific EMPAD G2 detector are key drivers for Thermo Fisher Scientific's growth in the analytical instruments business.
• Despite the positive analyst outlook, Thermo Fisher Scientific faces market headwinds, including a recent daily stock drop of 1.75% and broader market uncertainty.

Thermo Fisher Scientific Inc. (NYSE: TMO) is a global leader in the life sciences sector. The company provides analytical instruments, equipment, software, and services for research, analysis, and diagnostics. It operates in a competitive market, facing challenges from broad economic risks and other industry players.

On September 8, 2026, an analyst from UBS upgrades Thermo Fisher Scientific to a "Buy" rating from "Neutral." The firm sets a new price target of $730.00 for the stock. This target represents a potential upside of about 21.06% from its price of $603.02 at the time of the announcement, as reported by TheFly.

This positive outlook is supported by recent company developments. As highlighted by Zacks Investment Research, strategic acquisitions are helping Thermo Fisher Scientific grow. The company also recently launched its new Thermo Scientific EMPAD G2 detector, which is expected to strengthen its Analytical Instruments business by enabling faster and more detailed materials analysis.

Despite the upgrade, Thermo Fisher Scientific faces market headwinds. The stock recently saw a daily drop of 1.75%, or $10.76, closing at $603.02. This occurs amid broader market uncertainty and competitive pressures, as highlighted by 247 Wallst. The stock's daily trading fluctuated between a low of $596.57 and a high of $608.10.

Thermo Fisher Scientific has a market capitalization of approximately $224.09 billion, which is the total value of all its shares. Over the past year, the stock has traded as high as $647.00 and as low as $435.27. The recent trading day saw a volume of 2.65 million shares exchanged.